Researchers have developed and preliminarily tested a composite score that simultaneously assesses the severity of asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) in patients with both ...

Learn the essential facts about fungal sinus infections, from recognizing early warning signs to understanding treatment ...

Standard care for CRSwNP consists of corticosteroids in the nose ... and 25% to 30% of them develop nasal polyps as a result. Sanofi and Regeneron have said that CRSwNP has been helping to ...

PARIS, France I April 15, 2025 I Sanofi today shared new progress from its mid- to late-stage respiratory pipeline, including preliminary phase 2 results for ...

Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthmaLunsekimig ...

The readout of the phase 2 study in patients with chronic rhinosinusitis with nasal polyps (clinical study ... with medium-to-high doses of inhaled corticosteroids and up to two other controllers.

Simultaneously, the three regulators are also reviewing a second potential indication for depemokimab as an add-on therapy for chronic rhinosinusitis with nasal polyps (CRSwNP). GSK has said ...

Asthma and Antibiotic Use May Predict Nasal Polyp Recurrence After Endoscopic ... is more effective than the current treatment of steroid tablets, reducing the need for further treatment by ...

This is the case for most sinus infections. Symptoms of viral sinus infections may be treated with the following: Nasal polyps may be treated with intranasal or oral corticosteroids to shrink their ...

the need of systemic steroid use remains high, which is associated with adverse effects such as infections, diabetes, obesity, osteoporosis, cardiovascular disease, and cataracts. Furthermore, 40% of ...